Two Sigma Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-170,136
| Closed | -$517K | – | 3592 |
|
|
2024
Q4 | $517K | Buy |
170,136
+13,539
| +9% | +$59K | ﹤0.01% | 2525 |
|
|
2024
Q3 | $813K | Sell |
156,597
-477,306
| -75% | -$2.37M | ﹤0.01% | 2236 |
|
|
2024
Q2 | $1.63M | Buy |
633,903
+376,506
| +146% | +$1.29M | ﹤0.01% | 1689 |
|
|
2024
Q1 | $1.27M | Buy |
+257,397
| New | +$1.52M | ﹤0.01% | 1792 |
|
|
2023
Q3 | – | Sell |
-816,839
| Closed | -$20.7M | – | 3283 |
|
|
2023
Q2 | $20.7M | Sell |
816,839
-557,499
| -41% | -$17.4M | 0.05% | 401 |
|
|
2023
Q1 | $44.3M | Buy |
1,374,338
+23,184
| +2% | +$723K | 0.13% | 193 |
|
|
2022
Q4 | $24.9M | Buy |
1,351,154
+229,331
| +20% | +$5.25M | 0.08% | 288 |
|
|
2022
Q3 | $30.3M | Buy |
1,121,823
+777,135
| +225% | +$15.8M | 0.1% | 244 |
|
|
2022
Q2 | $4.76M | Buy |
344,688
+235,292
| +215% | +$3.62M | 0.02% | 799 |
|
|
2022
Q1 | $2.13M | Buy |
109,396
+20,590
| +23% | +$312K | 0.01% | 1324 |
|
|
2021
Q4 | $1.45M | Buy |
+88,806
| New | +$1.48M | ﹤0.01% | 2223 |
|
|
2020
Q4 | – | Sell |
-32,722
| Closed | -$823K | – | 3861 |
|
|
2020
Q3 | $823K | Buy |
32,722
+19,613
| +150% | +$514K | ﹤0.01% | 1893 |
|
|
2020
Q2 | $320K | Sell |
13,109
-114,858
| -90% | -$2.27M | ﹤0.01% | 2331 |
|
|
2020
Q1 | $1.89M | Buy |
127,967
+76,065
| +147% | +$1.57M | 0.02% | 997 |
|
|
2019
Q4 | $842K | Buy |
+51,902
| New | +$805K | ﹤0.01% | 2338 |
|
|
2019
Q3 | – | Sell |
-36,242
| Closed | -$470K | – | 3870 |
|
|
2019
Q2 | $470K | Sell |
36,242
-80,770
| -69% | -$1.02M | ﹤0.01% | 2546 |
|
|
2019
Q1 | $1.84M | Buy |
+117,012
| New | +$2.03M | 0.01% | 1473 |
|
|
2018
Q4 | – | Sell |
-39,039
| Closed | -$970K | – | 3631 |
|
|
2018
Q3 | $970K | Sell |
39,039
-106,638
| -73% | -$2.9M | ﹤0.01% | 2003 |
|
|
2018
Q2 | $4M | Buy |
145,677
+97,822
| +204% | +$2.94M | 0.01% | 1153 |
|
|
2018
Q1 | $1.47M | Sell |
47,855
-36,287
| -43% | -$1.17M | ﹤0.01% | 1749 |
|
|
2017
Q4 | $3.01M | Buy |
+84,142
| New | +$2.42M | 0.01% | 1207 |
|
|
2016
Q1 | – | Sell |
-48,146
| Closed | -$1.65M | – | 3189 |
|
|
2015
Q4 | $1.65M | Buy |
+48,146
| New | +$1.67M | 0.01% | 1195 |
|
|
2015
Q2 | – | Sell |
-51,673
| Closed | -$1.07M | – | 3156 |
|
|
2015
Q1 | $1.07M | Buy |
+51,673
| New | +$893K | 0.01% | 1532 |
|
Other funds holding RVNC
Two Sigma Investments's RVNC Position: Q1 2025 in Review
Two Sigma Investments sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 170,136 shares — an estimated $517K sold.
Two Sigma Investments first reported a position in RVNC in Q1 2015 and held it in 23 quarters. The position peaked at $44.3M in Q1 2023. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- Two Sigma Investments reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- Two Sigma Investments sold 170,136 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $517K.
- Two Sigma Investments first reported a position in Revance Therapeutics, Inc. in Q1 2015 and held it in 23 quarters.
- Two Sigma Investments's Revance Therapeutics, Inc. position peaked at $44.3M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.